Posttransplant Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Posttransplant Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus [Phase 2, Phase 3]
A Phase 2/3 trial is planned to evaluate semaglutide for preventing posttransplant diabetes mellitus in kidney transplant recipients, and th…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Silymarin's Advantage on Graft Effectiveness [Phase 3]
Phase 3 clinical trial update indicating enrollment by invitation for Silymarin to improve graft effectiveness in transplant patients.
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients [Phase 3]
Phase 3 trial update showing results on efficacy, mechanisms and safety of SGLT2 inhibitors in kidney transplant recipients; the study inclu…
-
CLINICAL_TRIALS research · 2024-02-02Clinical Trial Update: Tacrolimus Formulation and Glucose Metabolism After Kidney Transplantation (TAGLUMET Trial) [Phase 4]
A Phase 4 clinical trial evaluating tacrolimus formulation and its effects on glucose metabolism in kidney transplant recipients with posttr…
-
CLINICAL_TRIALS trial_result · 2021-06-29Clinical Trial Update: Efficacy Study of Sitagliptin to Prevent New-onset Diabetes After Kidney Transplant [Phase 4]
Phase 4 trial update evaluating sitagliptin to prevent new-onset diabetes after kidney transplant has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: Empagliflozin in Post-Transplantation Diabetes Mellitus [Phase 2]
Phase 2 clinical trial update on empagliflozin for post-transplant diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients [Phase 3]
A Phase 3 study evaluating insulin therapy to prevent new-onset diabetes after transplantation in non-diabetic de novo kidney transplant rec…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Insulin Secretion and Advagraf [Phase 4]
Phase 4 trial update from the University of Oslo School of Pharmacy evaluating insulin secretion in patients with Posttransplant diabetes me…
-
CLINICAL_TRIALS trial_result · 2013-11-07Clinical Trial Update: New-onset Diabetes and Left Ventricular Hypertrophy in Renal Transplantation
Completed clinical trial investigating posttransplant diabetes mellitus and associated left ventricular hypertrophy and arterial stiffness i…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Diabetogenicity of Cyclosporine and Tacrolimus [Phase 4]
Phase 4 clinical trial evaluating whether cyclosporine and tacrolimus increase the risk of new-onset diabetes after transplantation.
-
CLINICAL_TRIALS trial_result · 2006-05-10Clinical Trial Update: Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients [Phase 4]
Phase 4 trial assessing the efficacy and safety of nateglinide in renal transplant recipients with posttransplant diabetes mellitus or impai…